JP2020506930A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020506930A5 JP2020506930A5 JP2019541717A JP2019541717A JP2020506930A5 JP 2020506930 A5 JP2020506930 A5 JP 2020506930A5 JP 2019541717 A JP2019541717 A JP 2019541717A JP 2019541717 A JP2019541717 A JP 2019541717A JP 2020506930 A5 JP2020506930 A5 JP 2020506930A5
- Authority
- JP
- Japan
- Prior art keywords
- betahistine
- pharmaceutical composition
- dose
- composition according
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022017792A JP2022051872A (ja) | 2017-02-02 | 2022-02-08 | ベタヒスチンを含む鼻腔内組成物 |
| JP2024000158A JP2024019731A (ja) | 2017-02-02 | 2024-01-04 | ベタヒスチンを含む鼻腔内組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762453931P | 2017-02-02 | 2017-02-02 | |
| US62/453,931 | 2017-02-02 | ||
| PCT/EP2018/052695 WO2018141922A1 (en) | 2017-02-02 | 2018-02-02 | Intranasal composition comprising betahistine |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022017792A Division JP2022051872A (ja) | 2017-02-02 | 2022-02-08 | ベタヒスチンを含む鼻腔内組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020506930A JP2020506930A (ja) | 2020-03-05 |
| JP2020506930A5 true JP2020506930A5 (enExample) | 2021-03-11 |
| JP7714323B2 JP7714323B2 (ja) | 2025-07-29 |
Family
ID=61187302
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019541717A Active JP7714323B2 (ja) | 2017-02-02 | 2018-02-02 | ベタヒスチンを含む鼻腔内組成物 |
| JP2022017792A Withdrawn JP2022051872A (ja) | 2017-02-02 | 2022-02-08 | ベタヒスチンを含む鼻腔内組成物 |
| JP2024000158A Pending JP2024019731A (ja) | 2017-02-02 | 2024-01-04 | ベタヒスチンを含む鼻腔内組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022017792A Withdrawn JP2022051872A (ja) | 2017-02-02 | 2022-02-08 | ベタヒスチンを含む鼻腔内組成物 |
| JP2024000158A Pending JP2024019731A (ja) | 2017-02-02 | 2024-01-04 | ベタヒスチンを含む鼻腔内組成物 |
Country Status (33)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018170532A1 (en) * | 2017-03-22 | 2018-09-27 | Franz, Lilian Ann | Treatment method |
| US20230338279A1 (en) * | 2020-04-14 | 2023-10-26 | Glaxosmithkline Consumer Healthcare Holdings (Us) Llc | Nasal spray formulation with moisturizing benefits |
| JP2023523410A (ja) * | 2020-04-22 | 2023-06-05 | サノタイズ リサーチ アンド ディベロップメント コープ． | 上気道感染症を治療するための組成物および方法 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2397840B1 (enExample) | 1977-07-22 | 1981-03-20 | Cherqui Jean | |
| IT1229237B (it) * | 1989-05-08 | 1991-07-26 | Prodotti Formenti | Sali di (2-(piridil)etil) metilammina |
| JPH03287535A (ja) * | 1990-03-31 | 1991-12-18 | Bairon Boeki Kk | プラノプロフェン水溶液 |
| JP3203056B2 (ja) * | 1992-08-13 | 2001-08-27 | 株式会社ティ・ティ・エス技術研究所 | メシル酸ベタヒスチンの経皮吸収製剤用組成物および経皮吸収製剤 |
| US5897858A (en) * | 1994-02-03 | 1999-04-27 | Schering-Plough Healthcare Products, Inc. | Nasal spray compositions exhibiting increased retention in the nasal cavity |
| JPH10139667A (ja) * | 1996-11-15 | 1998-05-26 | Yoshitomi Pharmaceut Ind Ltd | 水性液剤 |
| CA2446904A1 (en) | 2001-05-24 | 2003-04-03 | Alexza Molecular Delivery Corporation | Delivery of drug esters through an inhalation route |
| US7090830B2 (en) | 2001-05-24 | 2006-08-15 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
| JP3555598B2 (ja) | 2001-06-27 | 2004-08-18 | 株式会社村田製作所 | 積層型インダクタ |
| JP2004196676A (ja) * | 2002-12-16 | 2004-07-15 | Rohto Pharmaceut Co Ltd | 点鼻剤 |
| JP4733333B2 (ja) * | 2002-12-26 | 2011-07-27 | ライオン株式会社 | 点鼻剤又は洗鼻剤 |
| ES2258694T3 (es) | 2003-11-11 | 2006-09-01 | Mattern, Udo | Sistema de administracion de liberacion controlada de hormonas sexuales para aplicaciones nasales. |
| US7728015B2 (en) * | 2004-04-22 | 2010-06-01 | Mor Research Applications Ltd. | Compositions for weight management |
| WO2005101979A2 (en) | 2004-04-22 | 2005-11-03 | Mor Research Applications Ltd. | Method of food intake management |
| AU2006202950A1 (en) * | 2004-04-22 | 2006-10-19 | Mor Research Applications Ltd. | Methods and Compositions for Weight Management |
| US20060046962A1 (en) | 2004-08-25 | 2006-03-02 | Aegis Therapeutics Llc | Absorption enhancers for drug administration |
| EP1789075A4 (en) | 2004-08-25 | 2009-07-01 | Uab Research Foundation | ABSORPTION ENHANCER FOR DRUG ADMINISTRATION |
| US20070111964A1 (en) * | 2005-08-17 | 2007-05-17 | Fleming And Company, Pharmaceuticals | Vitamin B12 nasal spray and method of use |
| WO2007076140A2 (en) * | 2005-12-23 | 2007-07-05 | University Of Cincinnati | Treatment methods employing histamine h3 receptor antagonists, including betahistine |
| US8242148B2 (en) * | 2005-12-23 | 2012-08-14 | Nelson Erik B | Treatment methods employing histamine H3 receptor antagonists, including betahistine |
| US20080066739A1 (en) | 2006-09-20 | 2008-03-20 | Lemahieu Edward | Methods and systems of delivering medication via inhalation |
| MX2010006932A (es) * | 2007-12-21 | 2010-10-05 | Schering Plough Healthcare | Aumento de la fotoestabilizacion de la oximetazolina. |
| EP2278999B1 (en) * | 2008-04-21 | 2025-01-29 | Dompé farmaceutici S.p.A. | Auris formulations for treating otic diseases and conditions |
| US8642631B2 (en) * | 2008-05-27 | 2014-02-04 | University Of Melbourne | Methods of treating mammals with eustachian tube dysfunctions |
| CN102216257B (zh) * | 2008-10-08 | 2015-11-25 | 凯飞药业公司 | Gaba偶联物及其使用方法 |
| SMT202000576T1 (it) * | 2014-10-03 | 2020-11-10 | Lachesis Biosciences Ltd | Composizioni intranasali per il trattamento di malattie e disturbi neurologici e neurodegenerativi |
-
2018
- 2018-02-02 AR ARP180100254A patent/AR111699A1/es not_active Application Discontinuation
- 2018-02-02 EP EP20170448.3A patent/EP3698791B1/en active Active
- 2018-02-02 NZ NZ755931A patent/NZ755931A/en unknown
- 2018-02-02 MX MX2019008961A patent/MX381932B/es unknown
- 2018-02-02 PL PL20170448.3T patent/PL3698791T3/pl unknown
- 2018-02-02 PT PT201704483T patent/PT3698791T/pt unknown
- 2018-02-02 RS RS20240022A patent/RS65099B1/sr unknown
- 2018-02-02 CN CN202410176958.XA patent/CN118356397A/zh active Pending
- 2018-02-02 HU HUE20170448A patent/HUE065336T2/hu unknown
- 2018-02-02 DK DK18703749.4T patent/DK3474850T3/da active
- 2018-02-02 SI SI201831043T patent/SI3698791T1/sl unknown
- 2018-02-02 PT PT187037494T patent/PT3474850T/pt unknown
- 2018-02-02 WO PCT/EP2018/052695 patent/WO2018141922A1/en not_active Ceased
- 2018-02-02 EP EP18703749.4A patent/EP3474850B1/en active Active
- 2018-02-02 PL PL18703749T patent/PL3474850T3/pl unknown
- 2018-02-02 LT LTEP20170448.3T patent/LT3698791T/lt unknown
- 2018-02-02 CA CA3051725A patent/CA3051725A1/en active Pending
- 2018-02-02 MA MA46778A patent/MA46778B1/fr unknown
- 2018-02-02 MY MYPI2019004366A patent/MY196333A/en unknown
- 2018-02-02 LT LTEP18703749.4T patent/LT3474850T/lt unknown
- 2018-02-02 IL IL268353A patent/IL268353B2/en unknown
- 2018-02-02 TN TNP/2019/000220A patent/TN2019000220A1/en unknown
- 2018-02-02 ES ES18703749T patent/ES2807798T3/es active Active
- 2018-02-02 AU AU2018216970A patent/AU2018216970B2/en active Active
- 2018-02-02 SI SI201830082T patent/SI3474850T1/sl unknown
- 2018-02-02 JP JP2019541717A patent/JP7714323B2/ja active Active
- 2018-02-02 TW TW107103800A patent/TWI760429B/zh active
- 2018-02-02 CN CN201880017726.2A patent/CN110418643A/zh active Pending
- 2018-02-02 KR KR1020197025622A patent/KR102653545B1/ko active Active
- 2018-02-02 ES ES20170448T patent/ES2969301T3/es active Active
- 2018-02-02 US US15/887,388 patent/US10456386B2/en active Active
- 2018-02-02 HR HRP20201137TT patent/HRP20201137T1/hr unknown
- 2018-02-02 EA EA201991817A patent/EA201991817A1/ru unknown
- 2018-02-02 FI FIEP20170448.3T patent/FI3698791T3/fi active
- 2018-02-02 HU HUE18703749A patent/HUE050829T2/hu unknown
- 2018-02-02 RS RS20200851A patent/RS60554B1/sr unknown
- 2018-02-02 PH PH1/2019/501785A patent/PH12019501785B1/en unknown
- 2018-02-02 SG SG11201906980YA patent/SG11201906980YA/en unknown
- 2018-02-02 HR HRP20231706TT patent/HRP20231706T1/hr unknown
- 2018-02-02 DK DK20170448.3T patent/DK3698791T3/da active
-
2019
- 2019-07-26 SA SA519402324A patent/SA519402324B1/ar unknown
- 2019-07-29 ZA ZA2019/04955A patent/ZA201904955B/en unknown
- 2019-07-30 CL CL2019002145A patent/CL2019002145A1/es unknown
- 2019-08-09 CO CONC2019/0008657A patent/CO2019008657A2/es unknown
- 2019-09-13 US US16/570,156 patent/US20200022963A1/en not_active Abandoned
-
2022
- 2022-02-08 JP JP2022017792A patent/JP2022051872A/ja not_active Withdrawn
-
2024
- 2024-01-04 JP JP2024000158A patent/JP2024019731A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8450339B2 (en) | Compositions for treatment of common cold | |
| US20020193397A1 (en) | Nasal delivery of apomorphine | |
| AU2023202420A1 (en) | Compositions, devices, and methods for the treatment of alcohol use disorder | |
| JP2001517639A (ja) | 鼻炎／結膜炎および感冒、感冒に似た症状および／または流行性感冒の症状を局所的に治療するための、鎮静作用を有しない抗ヒスタミンおよびα−アドレナリン作動薬を含む組合せ物の使用 | |
| CA2661759A1 (en) | Buprenophine-wafer for drug substitution therapy | |
| WO2008002514A2 (en) | Combination cough treatment compounds and method of treating common coughs | |
| CA2522291A1 (en) | Nasal pharmaceutical formulations and methods of using the same | |
| JP2020506930A5 (enExample) | ||
| CN1154495C (zh) | 米氮平用于治疗睡眠性呼吸暂停的用途 | |
| FI3698791T3 (fi) | Intranasaalinen koostumus, joka käsittää betahistiiniä | |
| WO2002024202A1 (en) | Nasal delivery of apomorphine in combination with glycol derivatives | |
| WO2010038240A9 (en) | Pharmaceutical composition comprising nimesulide and levocetirizine | |
| JP2006501211A (ja) | エピナスチン、プソイドエフェドリン及びメチルエフェドリンの組み合せを含有する医薬組成物 | |
| US20090124606A1 (en) | Composition for Treatment of Psychosis | |
| JP2002523362A5 (enExample) | ||
| US20240408003A1 (en) | Compositions, devices and methods for the treatment of alcohol use disorder | |
| AU2002329578B2 (en) | Compositions for treatment of common cold | |
| MXPA06008935A (en) | Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids | |
| AU2002329578A1 (en) | Compositions for treatment of common cold | |
| HK1067984B (en) | Compositions comprising ipatropium and xylometazoline for treatment of the common cold | |
| HK1092064A (en) | Compositions comprising ipatropium and xylometazoline for treatment of the common cold |